LPAR1
LPAR1 (lysophosphatidic acid receptor 1, also known as LPA1, EDG2, edg-2 and vzg-1) is a G protein-coupled receptor for the signalling lipid lysophosphatidic acid (LPA). It regulates actin dynamics, cell migration, proliferation and differentiation. Browse Assay Genie's current range of LPAR1 research reagents below, or read on for the biology behind the target.
LPAR1 is a receptor for lysophosphatidic acid (LPA) and couples to several families of heteromeric G proteins: G(i)/G(o), G(12)/G(13) and G(q). Signalling through these routes inhibits adenylyl cyclase and lowers cellular cAMP, raises cytoplasmic Ca(2+), and activates downstream MAP kinases. LPAR1 also activates RALA, which leads to phospholipase C activation and formation of inositol 1,4,5-trisphosphate.
A major output of LPAR1 signalling is remodelling of the actin cytoskeleton. The receptor promotes Rho activation and actin stress fibre formation, drives neurite retraction in neuronal cells, and stimulates lamellipodia formation at the leading edge of migrating cells through RAC1. Through these actions it contributes to chemotaxis, cell migration, cell shape, and responses to injury and wounding. It also promotes proliferation in response to LPA and, via AKT1 activation, inhibits the intracellular ciliogenesis pathway. In response to bacterial lipopolysaccharide (LPS), it interacts with CD14 and helps trigger inflammation.
The LPAR1 gene encodes an integral membrane protein of the G protein-coupled receptor 1 family, found at the cell surface, in the cell membrane and in endosomes. It belongs to the EDG receptor group, and its earlier HGNC name was endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2. EDG receptors mediate functions including platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation and tumour cell invasion. LPAR1 is required for normal skeleton and brain development, may play a role in osteoblast differentiation, supports the proliferation, survival and maturation of new neurons in the adult dentate gyrus, and contributes to pain perception and the initiation of neuropathic pain. Many transcript variants encoding a few different isoforms have been reported.
LPAR1 couples to G(i)/G(o), G(12)/G(13) and G(q), making it a useful model for multi-pathway signalling by a lipid-activated receptor.
The receptor drives Rho-dependent stress fibre formation and RAC1-dependent lamellipodia, central to studies of chemotaxis, wound responses and tumour cell invasion.
LPAR1 is required for normal brain development, adult neurogenesis in the dentate gyrus, and the initiation of neuropathic pain.
LPAR1 contributes to LPS-triggered inflammation through CD14 and is required for normal skeleton development and possibly osteoblast differentiation.
LPAR1 is a receptor for lysophosphatidic acid. On binding LPA it signals through G(i)/G(o), G(12)/G(13) and G(q) proteins to lower cAMP, raise intracellular Ca(2+) and activate MAP kinases, thereby regulating actin organisation, cell migration, proliferation and differentiation.
LPAR1 is also called LPA1, EDG2, edg-2, vzg-1, rec.1.3, Mrec1.3 and Gpcr26. Its earlier HGNC name was endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2. NCBI notes that many transcript variants encoding a few different isoforms have been identified.
Mouse and rat both have an orthologue named Lpar1. The source annotation links LPAR1 to pain perception and the initiation of neuropathic pain, and to tumour cell invasion among EDG receptor functions. Check the datasheet of any product for its validated reactivity.
Other lysophosphatidic acid receptors in the same gene group, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92633; product specifications from Assay Genie datasheets.